ERIN STILSON: Open Payments
NPI 1922790534 · CLINTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,108 in 140 payments from 38 companies in 2025. Trend: 2023 $778 · 2024 $2,771 · 2025 $3,108
Food & beverage: $2,899Education: $209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $514 |
| Janssen Biotech, Inc. | 23 | $344 |
| Novartis Pharmaceuticals Corporation | 14 | $274 |
| AstraZeneca Pharmaceuticals LP | 12 | $225 |
| Merck Sharp & Dohme LLC | 9 | $191 |
| Novocure Inc. | 1 | $143 |
| Celgene Corporation | 5 | $92 |
| Eisai Inc. | 5 | $88 |
| SANOFI-AVENTIS U.S. LLC | 1 | $83 |
| TAIHO ONCOLOGY, INC. | 4 | $78 |
Products named: VENCLEXTA, KEYTRUDA, Optune Lua (NovoTTF-200T), Enhertu, KISQALI, SARCLISA, ERLEADA, CARVYKTI.
Industry payments across MO — which companies pay providers there.
